USD 1.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | - USD | 0.0% |
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q3 | - USD | 0.0% |
2024 Q4 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2024 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2015 Q2 | 29.82 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | 1152.00 USD | -96.14% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Bright Green Corporation | 401.49 Thousand USD | 100.0% |
Clever Leaves Holdings Inc. | 17.41 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 12.24 Million USD | 100.0% |
GSRX Industries Inc. | - USD | NaN% |
High Sierra Technologies, Inc. | - USD | NaN% |
Instadose Pharma Corp. | - USD | NaN% |